Ovarian Cancer News
The daily ovarian cancer news is a unique cancer news service that evaluates all aspects of ovarian cancer research and reports on the developments that are most important to cancer patients and health care providers. The daily cancer news provides information about emerging options for ovarian cancer prevention, early detection and ovarian cancer treatment, as well as advances in supportive care and personalized medicine. Supportive care improves quality of life by making ovarian cancer treatment more tolerable, and personalized medicine offers the potential for improved treatment outcomes by using specific characteristics of the patient or the cancer to guide cancer treatment decisions. In addition, interested individuals can search the Cancer Consultants Ovarian Cancer News Archives to find the results of the cancer studies that led to the care they have been offered.
Ovarian Cancer News
Novel Two-step Immunotherapy Shows Promise in Recurrent Ovarian Cancer (May 17, 2013)
A novel two-step immunotherapy approach yielded clinically beneficial responses in patients with advanced ovarian cancer, according to data from two phase I clinical trials presented at the American Association... Continue Reading
People who follow the diet and lifestyle recommendations laid out by the World Cancer Research Fund (WCRF) and the American Institute for Cancer Research (AICR) have a 34 percent reduced risk of dying... Continue Reading
Women with advanced ovarian cancer have significantly worse survival when they wait more than 25 days after surgery to start chemotherapy, according to the results of a study presented at the 2013 Society... Continue Reading
Sun Valley, ID and Boston, MA- CancerConnect has partnered with Dana-Farber Cancer Institute to provide you with the opportunity to engage with a gynecologic cancers expert, Ursula A. Matulonis, MD, who... Continue Reading
Overall cancer death rates continue to decline in both men and women and across major ethnic and racial groups, according to the annual Status of Cancer report published in the Journal of the National... Continue Reading
The rate of second primary ovarian cancers after first primary breast cancer appears to be on the decline, according to the results of a study published in the Journal of Clinical Oncology. Each year in... Continue Reading
Metformin, a widely prescribed insulin-lowering drug for diabetes, has been associated with survival in ovarian cancer and is worthy of further study, as it may be considered for the prevention or treatment... Continue Reading
Ovarian cancer patients who undergo surgery at high-volume hospitals have better outcomes than those who are treated at low-volume hospitals, according to the results of a study published in the Journal... Continue Reading
Women who regularly use aspirin may have a decreased risk of developing serous ovarian cancer, according to the results of a study published in Acta Obstetricia et Gynecologica Scandinavica. Ovarian cancer... Continue Reading
Measuring the activity of a gene called FGF1 could help predict which women with ovarian cancer will benefit from platinum-based chemotherapy, according to the results of a study published in the British... Continue Reading
Latest Ovarian Cancer News By Stage
Screening and Prevention
Ovarian Cancer Rates Declining in Breast Cancer Survivors (February 7, 2013)
The rate of second primary ovarian cancers after first primary breast cancer appears to be on the decline, according to the results of a study published in the Journal of Clinical Oncology. Each year in the United States, roughly 22,000 women are diagnosed... Continue Reading
Diabetes Drug May Help Prevent or Treat Ovarian Cancer (December 3, 2012)Metformin, a widely prescribed insulin-lowering drug for diabetes, has been associated with survival in ovarian cancer and is worthy of further study, as it may be considered for the prevention or treatment of ovarian cancer, according to the results... Continue Reading
Aspirin May Reduce Risk of Serous Ovarian Cancer (October 18, 2012)Women who regularly use aspirin may have a decreased risk of developing serous ovarian cancer, according to the results of a study published in Acta Obstetricia et Gynecologica Scandinavica. Ovarian cancer has the highest mortality rate of all gynecologic... Continue Reading
Dr. Chi and Dr. Bell-McGuinn from Memorial Sloan-Kettering Cancer Center Discuss Treatment Options for Ovarian Cancer (September 23, 2012)Treatment Options for Ovarian Cancer: Web Chat with Dennis S. Chi, MD, FACOG, FACS and Katherine M. Bell-McGuinn, MD, PhD Dennis S. Chi, MD Katherine M. Bell-McGuinn, MD, PhD Dr. Chi is the Deputy Chief of the Gynecology Service at Memorial Sloan-Kettering... Continue Reading
Healthy Women Need Not Undergo Screening for Ovarian Cancer (April 19, 2012)Healthy women at average risk for ovarian cancer do not need to get screened for the disease, according to the U.S. Preventive Services Task Force (USPSTF). After a recent review of the data, the government panel has renewed its 2004 recommendation against... Continue Reading
More Screening and PreventionStage I
Ovarian Cancer Rates Declining in Breast Cancer Survivors (February 7, 2013)
The rate of second primary ovarian cancers after first primary breast cancer appears to be on the decline, according to the results of a study published in the Journal of Clinical Oncology. Each year in the United States, roughly 22,000 women are diagnosed... Continue Reading
Diabetes Drug May Help Prevent or Treat Ovarian Cancer (December 3, 2012)Metformin, a widely prescribed insulin-lowering drug for diabetes, has been associated with survival in ovarian cancer and is worthy of further study, as it may be considered for the prevention or treatment of ovarian cancer, according to the results... Continue Reading
Treatment at High-Volume Hospitals Leads to Lower Mortality Rates for Ovarian Patients (November 20, 2012)Ovarian cancer patients who undergo surgery at high-volume hospitals have better outcomes than those who are treated at low-volume hospitals, according to the results of a study published in the Journal of Clinical Oncology. This is the result not of... Continue Reading
Gene Helps Predict Response to Chemotherapy in Ovarian Cancer (September 28, 2012)Measuring the activity of a gene called FGF1 could help predict which women with ovarian cancer will benefit from platinum-based chemotherapy, according to the results of a study published in the British Journal of Cancer. Each year in the United States,... Continue Reading
Dr. Chi and Dr. Bell-McGuinn from Memorial Sloan-Kettering Cancer Center Discuss Treatment Options for Ovarian Cancer (September 23, 2012)Treatment Options for Ovarian Cancer: Web Chat with Dennis S. Chi, MD, FACOG, FACS and Katherine M. Bell-McGuinn, MD, PhD Dennis S. Chi, MD Katherine M. Bell-McGuinn, MD, PhD Dr. Chi is the Deputy Chief of the Gynecology Service at Memorial Sloan-Kettering... Continue Reading
More Stage IStages II-IV
Delaying Chemotherapy Increases Mortality in Ovarian Cancer (April 12, 2013)
Women with advanced ovarian cancer have significantly worse survival when they wait more than 25 days after surgery to start chemotherapy, according to the results of a study presented at the 2013 Society of Gynecologic Oncology Annual Meeting on Women’s... Continue Reading
Ovarian Cancer Rates Declining in Breast Cancer Survivors (February 7, 2013)The rate of second primary ovarian cancers after first primary breast cancer appears to be on the decline, according to the results of a study published in the Journal of Clinical Oncology. Each year in the United States, roughly 22,000 women are diagnosed... Continue Reading
Diabetes Drug May Help Prevent or Treat Ovarian Cancer (December 3, 2012)Metformin, a widely prescribed insulin-lowering drug for diabetes, has been associated with survival in ovarian cancer and is worthy of further study, as it may be considered for the prevention or treatment of ovarian cancer, according to the results... Continue Reading
Treatment at High-Volume Hospitals Leads to Lower Mortality Rates for Ovarian Patients (November 20, 2012)Ovarian cancer patients who undergo surgery at high-volume hospitals have better outcomes than those who are treated at low-volume hospitals, according to the results of a study published in the Journal of Clinical Oncology. This is the result not of... Continue Reading
Gene Helps Predict Response to Chemotherapy in Ovarian Cancer (September 28, 2012)Measuring the activity of a gene called FGF1 could help predict which women with ovarian cancer will benefit from platinum-based chemotherapy, according to the results of a study published in the British Journal of Cancer. Each year in the United States,... Continue Reading
More Stages II-IVRecurrent
Novel Two-step Immunotherapy Shows Promise in Recurrent Ovarian Cancer (May 17, 2013)
A novel two-step immunotherapy approach yielded clinically beneficial responses in patients with advanced ovarian cancer, according to data from two phase I clinical trials presented at the American Association for Cancer Research (AACR) Annual Meeting... Continue Reading
Ovarian Cancer Rates Declining in Breast Cancer Survivors (February 7, 2013)The rate of second primary ovarian cancers after first primary breast cancer appears to be on the decline, according to the results of a study published in the Journal of Clinical Oncology. Each year in the United States, roughly 22,000 women are diagnosed... Continue Reading
Diabetes Drug May Help Prevent or Treat Ovarian Cancer (December 3, 2012)Metformin, a widely prescribed insulin-lowering drug for diabetes, has been associated with survival in ovarian cancer and is worthy of further study, as it may be considered for the prevention or treatment of ovarian cancer, according to the results... Continue Reading
Treatment at High-Volume Hospitals Leads to Lower Mortality Rates for Ovarian Patients (November 20, 2012)Ovarian cancer patients who undergo surgery at high-volume hospitals have better outcomes than those who are treated at low-volume hospitals, according to the results of a study published in the Journal of Clinical Oncology. This is the result not of... Continue Reading
Gene Helps Predict Response to Chemotherapy in Ovarian Cancer (September 28, 2012)Measuring the activity of a gene called FGF1 could help predict which women with ovarian cancer will benefit from platinum-based chemotherapy, according to the results of a study published in the British Journal of Cancer. Each year in the United States,... Continue Reading
More Recurrent
